Adding continuous progestin to estrogen lowers the risk of endometrial cancer in postmenopausal women, according to a study recently published in the Journal of the National Cancer Institute.
Early menopause typically lowers the risk of most types of breast cancer. For women who reach menopause prematurely, the protective benifits of hormone therapy usually outweigh the risks.
